Omics in Urologic Research-New Frontiers Driving Precision Medicine
Omics in Urologic Research-New Frontiers Driving Precision Medicine
批准号:
8832101
负责人:
Allen C Gao
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-08 至 2015-08-31
关键词:
AgeAmericanAreaAutomobile DrivingAwardBasic ScienceBenign Prostatic HypertrophyBiological MarkersBladder DiseasesClinicalClinical ResearchClinical SciencesCollaborationsCommunitiesComplexDataDevelopmentDiagnosisDiagnosticDisciplineDiseaseDisease ProgressionEnsureErectile dysfunctionFacultyFemaleFibrosisFundingFunding OpportunitiesGenderGenitourinary systemGenomicsGoalsHealth Care CostsHumanIndividualInterstitial CystitisKnowledgeLeadMalignant neoplasm of prostateMedicineMinorityModelingMolecular TargetOralPathway interactionsPelvic PainPhysiciansPhysiologicalPopulationPostdoctoral FellowPreventionProcessProteomicsQuality of lifeResearchResearch PersonnelResourcesRestScientistSocietiesSolutionsSourceStudentsSyndromeSystemTechniquesTechnologyTherapeuticTissuesTrainingTranslationsTravelUnderrepresented MinorityUnited StatesUrologic CancerUrologic DiseasesWorkabstractingbasebench to bedsidecareerclinical applicationcontinuing medical educationcostdisease mechanisms studyexperiencefallsfrontiergraduate studenthealth disparityhuman diseasehuman tissueimprovedinnovationinterestlecturesmalemeetingsmembermetabolomicsminority traineemolecular markermultidisciplinarynovelnovel strategiespostersprofessorprognosticpublic health relevancesuccesssymposiumtranscriptomicstreatment responsetreatment strategyurologic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This R13 proposal seeks funds to provide 25 travel awards of $500 each to the most promising trainee investigators (Graduate Students, Residents, Clinician-Scientist / Post-Doctoral Trainees and faculty below the rank of Assistant Professor) and to increase representation by Underserved Minorities of this status to attend and participate in the 2014 Annual Fall Symposium of the Society for Basic Urological Research (SBUR) to be held November 13th -16th in Dallas, TX. The SBUR is a society of scientists and physician- scientists specializing in research on the normal and pathological conditions of tissues of the human genitourinary (GU) tract. GU developmental anomalies and diseases afflict males and females, young and old, and cost the US approximately $11 Billion a year in health costs. The overall objective of the annual Symposium is to share new findings at a multidisciplinary level, to promote interaction among members and other interested scientists, to inspire and promote the success of trainee scientists, and to highlight new areas of research and funding opportunities. This year, the theme of the Symposium is "Omics in Urologic Research: New Frontiers Driving Precision Medicine." The specific goals of this Symposium are: 1) to inspire young and established investigators to utilize current knowledge in the field to advance the frontiers of basic and translational urologic research; 2) to promote and advance the careers of new investigators in the field of urologic research; 3) to provide a forum for networking, interaction, and establishing new collaborations between investigators focused in GU development and disease those from other disciplines, and 4) to celebrate the excellence, depth, and diversity of basic urologic research pursued by the members of the organization. Research topics that will be covered during the Symposium include: Omics: Drivers from bench to bedside; Emerging transcriptomics and novel pathways; Models and disparity in urologic diseases; Molecular markers and targets for urologic diseases; and emerging treatment strategies for advanced urologic cancer. All invited speakers are leaders in their respective fields, offering extensive knowledge and experience to the audience. Selection of travel awardees will proceed through a defined process whereby applicants are ranked by the Abstract Review Sub-Committee, which works with the Executive Council of the SBUR to issue individual awards to promising and exceptional Trainee applicants. The Executive Council ensures effective representation of both genders in the awardees and, through a specific campaign, seeks applicants of Underrepresented Minority populations. If funded, this project will contribute to the educational objectives of the meeting by enhancing participation of bright and promising Junior Investigators, Physician-Scientist and Postdoctoral Trainees and Students and increase participation in research by members of underserved minority Trainees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer
-
批准号:10573314
-
项目类别:
-
资助金额:$52.11万
-
财政年份:2022
-
负责人:Allen C Gao
-
依托单位:
Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer
-
批准号:10449648
-
项目类别:
-
资助金额:$54.34万
-
财政年份:2022
-
负责人:Allen C Gao
-
依托单位:
Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer
-
批准号:10808574
-
项目类别:
-
资助金额:$7.36万
-
财政年份:2022
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting steroid sulfatase for advanced prostate cancer
-
批准号:10057773
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10618241
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting steroid sulfatase for advanced prostate cancer
-
批准号:10426197
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting Wnt5A signaling for advanced prostate cancer
-
批准号:10526399
-
项目类别:
-
资助金额:$37.4万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10454105
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting steroid sulfatase for advanced prostate cancer
-
批准号:10622544
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting steroid sulfatase for advanced prostate cancer
-
批准号:10737796
-
项目类别:
-
资助金额:$7.66万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting Wnt5A signaling for advanced prostate cancer
-
批准号:10310519
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting steroid sulfatase for advanced prostate cancer
-
批准号:10598320
-
项目类别:
-
资助金额:$7.33万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Targeting AR variants in advanced prostate cancer
-
批准号:10318581
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2019
-
负责人:Allen C Gao
-
依托单位:
Targeting AR variants in advanced prostate cancer
-
批准号:10538636
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2019
-
负责人:Allen C Gao
-
依托单位:
Novel mechanisms of resistance to antiandrogen therapies
-
批准号:10570826
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Allen C Gao
-
依托单位:
Novel mechanisms of resistance to antiandrogen therapies
-
批准号:10266014
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Allen C Gao
-
依托单位:
The role of p52 in prostate cancer
-
批准号:8732152
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Allen C Gao
-
依托单位:
The role of p52 in prostate cancer
-
批准号:8900114
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Allen C Gao
-
依托单位:
The role of p52 in prostate cancer
-
批准号:9339572
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Allen C Gao
-
依托单位:
Novel roles of microRNA in androgen receptor signaling
-
批准号:8634069
-
项目类别:
-
资助金额:$31.09万
-
财政年份:2013
-
负责人:Allen C Gao
-
依托单位:
海外基金